Amazon (NSDQ:AMZN) will be offering select consumer-use medical device for diabetes and hypertension management, according to a press release from the Arcadia Group.
The UK-based Arcadia Group said they are launching a new line of such devices under the brand Choice, looking to enter into the field by offering blood glucose monitors and blood pressure monitors that will be smartphone connectable.
The new Choice brand will offer conventional models and Bluetooth connectible versions, according to a press release. The company said that it previously developed Walmart’s ReliOn brand and Abbott‘s (NYSE:ABT) Freestyle line of diabetes devices.
“The Choice brand is all about accessible wellness. Consumers no longer need to drive to a store to stand in-line and purchase their medical devices and supplies. Now, in the privacy of their home, consumers can review, compare and purchase the products of their choice. No insurance is required. Therefore, customers have the freedom of choice. They will no longer be told by their insurance company what brand they can by. Choice is freedom. Our products are best in class and very affordable. Over time we intend to incorporate voice driven measurement interpretation as well as individualize wellness recommendations. This is all possible with Alexa, and will provide patients with a wellness experience not available until now,” Arcadia Group CEO Bob Guest said in a press release.
A recent report from The Telegraph suggests that future generations of Amazon’s Alexa virtual assistant may be able to determine when its users are ill and provide medication recommendations.
